Tufts University

Dr. Silvia Formenti and Dr. Massimo Loda, both at Weill Cornell Medicine, were elected to the National Academy of Medicine for their significant contributions to advancing medical sciences, health care, and public health. Formenti, a leader in radiation oncology and breast cancer research, pioneered combining radiation and immunotherapy, while Loda's work in molecular pathology highlighted prostate cancer metabolism, leading to targeted therapies.

Kyverna Therapeutics appoints biotechnology executive Mert Aktar as an independent director to its Board of Directors, enhancing expertise in corporate strategy and cell therapy.

Massachusetts LTC residents with documented penicillin allergy were 95% less likely to receive beta-lactam antibiotics, highlighting the need for improved allergy assessments and delabeling strategies.

Massachusetts LTC residents with documented penicillin allergy were 95% less likely to receive beta-lactam antibiotics, highlighting the need for improved allergy assessments and delabeling strategies.

The 39th AAAI Conference features workshops on AI advancements, including AI for public missions, social impact, urban planning, governance, and more. Topics span from AI in education, cybersecurity, music, to quantum computing, focusing on ethical AI, privacy, and societal benefits. Workshops aim to foster collaboration, share insights, and inspire new research directions in AI.

Find The Cause Breast Cancer Foundation, led by four scientists, focuses on preventing breast cancer through environmental chemical research. Their work aims to identify carcinogens and develop non-toxic drugs to block cancer formation. The organization invites participation in the Prevention Party on Oct. 24 to support their life-saving research.

FDA approves home use of FluMist nasal spray flu vaccine, offering convenience and accessibility. FluMist, effective for ages 2-49, addresses logistical and needle phobia issues, though not for immunocompromised or pregnant women. Available from 2024, it requires a prescription and aims to improve vaccine compliance.

The AVMA’s Veterinary Clinical Trials Registry connects clinical scientists with veterinarians and owners for animal health studies. It features improved browsing, sharing, and study submission processes. Recent studies include treatments for oral cancer in cats, canine hemangiosarcoma, osteosarcoma in dogs, and more.

Despite increased R&D spending, clinical trial productivity remains low. Key factors driving up costs include slow trial speed, inefficient patient recruitment, and lack of infrastructure. Integrated technology solutions like Anju's TrialMaster can streamline operations, offering features such as fast study builds, seamless integration, support for central labs, risk-based quality management, and user-friendly interfaces to improve efficiency and reduce costs.

Lifestyle changes like quitting smoking, improving diet, exercising, and getting vaccinated can significantly reduce cancer risks. Smoking is the top modifiable risk factor, followed by obesity, alcohol, UV radiation, and inactivity. Eating whole foods, moving more, quitting smoking, wearing sunscreen, and getting vaccinated against HPV and hepatitis can lower cancer risks.